HADS Anxiety | Â | Calendar Time by every 6 months | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Mar 2018-Aug 2018 | Sep 2018-Feb 2019 | Mar 2019-Aug 2019 | Sep 2019-Mar 2020 | Apr 2020 – Aug 2020 | Sep 2020-Feb 2021 | Mar 2021-Apr 2021 | Total | |||
Normal/Mild | 263 | 301 | 384 | 405 | 0 | 220 | 149 | 1722 | ||
Moderate/Severe | 101 | 82 | 141 | 118 | 0 | 89 | 50 | 581 | ||
Total | 364 | 383 | 525 | 523 | n/a | 309 | 199 | 2303 | ||
% | 27.7% | 21.4% | 26.9% | 22.6% | n/a | 28.8% | 25.1% | Â | ||
OR | 95% CI | p-value | Â | Â | Â | Â | Â | |||
1.03 | 0.94 | 1.12 | 0.572 | Â | Â | Â | Â | Â | ||
HADS Depression | Mar 2018-Aug 2018 | Sep 2018-Feb 2019 | Mar 2019-Aug 2019 | Sep 2019-Mar 2020 | Apr 2020 – Aug 2020 | Sep 2020-Feb 2021 | Mar 2021-Apr 2021 | Total | ||
Normal/Mild | 342 | 357 | 499 | 486 | 0 | 269 | 172 | 2125 | ||
Moderate/Severe | 23 | 27 | 27 | 37 | 0 | 42 | 27 | 183 | ||
Total | 365 | 384 | 526 | 523 | n/a | 311 | 199 | 2308 | ||
% | 6.3% | 7.0% | 5.1% | 7.1% | n/a | 13.5% | 13.6% | Â | ||
OR | 95% CI | p-value | Â | Â | Â | Â | Â | |||
1.35 | 1.17 | 1.56 | < 0.001 |  |  |  |  |  | ||
Polysubstance use in P6M | Mar 2018-Aug 2018 | Sep 2018-Feb 2019 | Mar 2019-Aug 2019 | Sep 2019-Mar 2020 | Apr 2020 – Aug 2020 | Sep 2020-Feb 2021 | Mar 2021-Apr 2021 | Total | ||
No | 208 | 215 | 304 | 301 | 0 | 190 | 132 | 1350 | ||
Yes | 159 | 176 | 229 | 225 | 0 | 123 | 69 | 981 | ||
Total | 367 | 391 | 533 | 526 | n/a | 313 | 201 | 2331 | ||
% | 43.3% | 45.0% | 43.0% | 42.8% | n/a | 39.3% | 34.3% | Â | ||
OR | 95% CI | p-value | Â | Â | Â | Â | Â | |||
0.89 | 0.82 | 0.97 | 0.007 | Â | Â | Â | Â | Â | ||
High risk or Harmful Drinking measured by AUDIT-C | Mar 2018-Aug 2018 | Sep 2018-Feb 2019 | Mar 2019-Aug 2019 | Sep 2019-Mar 2020 | Apr 2020 – Aug 2020 | Sep 2020-Feb 2021 | Mar 2021-Apr 2021 | Total | ||
Score less than 4 | 166 | 185 | 276 | 304 | 0 | 189 | 132 | 1252 | ||
Score 4 or more | 201 | 201 | 260 | 232 | 0 | 129 | 72 | 1095 | ||
Total | 367 | 386 | 536 | 536 | n/a | 318 | 204 | 2347 | ||
% | 54.8% | 52.1% | 48.5% | 43.3% | n/a | 40.6% | 35.3% | Â | ||
OR | 95% CI | p-value | Â | Â | Â | Â | Â | |||
0.74 | 0.67 | 0.81 | < 0.001 |  |  |  |  |  |